6533b829fe1ef96bd128ac5b

RESEARCH PRODUCT

T1078 The Validity of a Biomarker Method for Indirect Detection of Gastric Mucosal Atrophy Versus Standard Histopathology

Konrads FunkaLimas KupčinskasAudrius IvanauskasMarcis LejaDainius JančiauskasHan-mo ChiuAgnese SudrabaLaimas Virginijus JonaitisJaw-town Lin

subject

medicine.medical_specialtyPathologyHepatologybiologybusiness.industryAtrophic gastritisdigestive oral and skin physiologyGastroenterologymedicine.diseaseGastroenterologyIncreased riskAtrophyPepsinInternal medicinemedicinebiology.proteinBiomarker (medicine)HistopathologyCancer developmentbusinessGastric mucosal atrophy

description

Background Atrophy of the stomach mucosa is considered to be premalignant lesion for gastric cancer development; easy identification of this condition from a blood-sample would allow identifying the group of individuals at increased risk for cancer development.

https://doi.org/10.1016/s0016-5085(08)62239-8